Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
COLL
#1925
Collegium Pharmaceutical, Inc. Common Stock
41.670
0
-5.37%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-5.37%
Changement Mensuel
-7.99%
Evolution sur 6 mois
+18.58%
Changement Annuel
+18.58%
Clôture Précédente
44.035
0
Open
41.670
0
Bid
Ask
Low
41.670
0
High
41.670
0
Volume
114
Marchés
Actions des Marchés US
Soins de Santé
COLL
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
32.25 M
31.49 M
32.14 M
31.5 M
31.61 M
31.75 M
—
Valuation ratios
Enterprise value
1.21 B
831.5 M
863.25 M
814.17 M
955.97 M
1.24 B
3.87 B
Price to earnings ratio
15.9
15.4
24.47
28.43
21.73
26.76
101.4
Price to sales ratio
2.64
1.83
1.71
1.58
1.75
—
—
Price to cash flow ratio
8.23
5.65
5.71
5.47
4.59
5.58
21.35
Price to book ratio
1.82
5.06
1.24
1.2
1.36
6.09
9.9
Enterprise value to EBITDA ratio
2.86
4.68
2.43
2.46
2.88
—
—
Profitability ratios
Return on assets %
0.01
0.01
0
0.01
0.02
0.01
0.04
Return on equity %
0.04
0.05
0.01
0.05
0.11
0.06
0.23
Return on invested capital %
6.51
6.88
4.29
6.69
12.75
10.44
34.17
Gross margin %
60.76
54.02
54.75
57.65
61.7
62.49
236.59
Operating margin %
21.87
20.95
12.2
18.67
29.66
29.57
90.1
EBITDA margin %
74.12
22.09
44.61
49.36
57.18
165.52
316.67
Net margin %
5.86
6.89
1.36
6.37
15.05
8.26
31.04
Liquidity ratios
Quick ratio
0.88
0.88
1.01
1.1
1.27
1.48
4.86
Current ratio
0.97
0.95
1.08
1.18
1.36
1.57
5.19
Inventory turnover
1.9
2.27
2.21
2.11
2.1
1.95
8.38
Asset turnover
0.12
0.11
0.11
0.12
0.13
0.13
0.48
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.49
0.47
0.47
0.48
0.46
0.49
1.9
Long term debt to total equity ratio
3.43
3.44
3.3
3.27
2.71
2.68
11.95
Per share metrics
Operating cash flow per share
-0.22
2.09
1.69
1.85
1.99
3.07
8.6
EBIT per share
0.87
0.94
0.66
0.9
1.57
1.52
4.65
EBITDA per share
2.94
0.99
2.41
2.37
3.04
8.49
16.31
Total debt per share
—
—
—
—
—
—
—
Cash per share
5
6.36
9.12
8.37
10.79
13.53
41.8
Net current asset value per share
11.05
11.93
16.06
14.06
15.56
17.25
62.94
Tangible book value per share
-21.38
-20.41
-22.91
-17.82
-15.11
-12.82
-68.66
Working capital per share
-0.39
-0.67
1.24
2.17
4.08
6.27
13.76
Book value per share
5.83
5.66
7.14
5.94
6.97
7.53
27.58
Nouvelles
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
Collegium Q4 2025 slides: ADHD drug surges despite earnings miss
Le BPA de Collegium Pharmaceutical a manqué les attentes de 0,10$, le CA en dessous des prévisions
Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates
Résultats de Collegium Pharmaceutical : focus sur Jornay PM
Collegium Pharmaceutical earnings ahead: Jornay PM in focus
Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?
Collegium Pharmaceutical to Report Q4 Earnings: What's in the Cards?
Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates
Truist Securities raises Collegium Pharmaceutical stock price target to $58
Collegium Pharmaceutical Stock: Buying The Projected Growth For 2026 (NASDAQ:COLL)
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?